gastric juice protein comes up often in conversation and rarely with the context attached. Here we lay out the basics in order, then work through the practical considerations.
Last reviewed on 2026-01-29. Where a claim depends on a specific study, the study is described rather than over-claimed.
Direct human evidence is scarce. One trial in ulcerative colitis delivered the compound by enema and produced limited publicly reported results without a clear benefit. The compound is not an approved medicine in most jurisdictions. In many markets it is sold as a research chemical; in others it falls under prescription or controlled categories. Regulators have not confirmed any claimed medical use, and product labels rarely undergo premarket review.
Most published reports describe experiments in rodents rather than in people. These studies examine outcomes in tendons, ligaments, bone, stomach lining, and intestinal tissue. In rat and mouse models, a frequently reported effect is faster healing or reduced damage. Sample sizes are usually small, and a substantial share of the work originates from a small number of research groups. Independent replication is limited, so how far the findings extend to humans remains an open question.
The main chemical liabilities of this sequence are peptide-bond hydrolysis and possible aspartate-related reactions, since the peptide contains aspartic acid residues but no cysteine, methionine, or tryptophan. Absence of those three residues removes the most common oxidation and disulfide pathways from consideration. Studies of related peptides indicate that aspartate isomerisation and aspartimide formation occur most readily at Asp-Gly and Asp-Ala positions, and open questions remain about how quickly those reactions proceed under ordinary laboratory conditions. Storage guidance typically emphasises cool, dry, dark conditions to slow hydrolysis.
Identity and purity are usually assessed with reversed-phase high-performance liquid chromatography, often paired with mass spectrometry using electrospray or MALDI ionisation. Amino acid analysis and peptide mapping by enzymatic digestion provide additional sequence-level confirmation. Purity is commonly reported as an area percentage from a chromatographic trace, and water content can be measured by Karl Fischer titration. Reported masses may differ by tens of daltons between sources because preparations can contain acetate or trifluoroacetate counterions, and such differences are not by themselves evidence of a different peptide.
BPC-157 is normally distributed as a lyophilised powder that ranges from white to off-white in appearance. The peptide dissolves readily in water, normal saline, and common aqueous buffers, and it is poorly soluble in nonpolar solvents such as hexane or vegetable oils. Lyophilised vials take up moisture if left open, which changes the mass of powder in the container and complicates any later weighing. Because the material is handled in small quantities, static and adhesion to glass or plastic can also cause noticeable losses during transfer.
| Property | Value | Notes |
|---|---|---|
| Main study model | Rodents, rats and mice | Underpins most of the published data |
| Common routes in studies | Subcutaneous, intraperitoneal, oral | Varies with the experimental design |
| Common analytical method | Reversed-phase HPLC, LC-MS | Used for identity and purity checks |
| Human evidence base | Small | Few trials reported, with limited findings |
| Regulatory status | Varies by jurisdiction | Not an approved medicine in most places |
Within the research literature, the peptide is discussed through several provisional mechanisms, including cytoprotection, modulation of growth factor signaling, and interaction with the nitric oxide system. None of these mechanisms is fully characterized, and no single pathway is universally accepted. Review articles typically note the gap between consistent animal findings and sparse human evidence. The compound is classified as a research chemical rather than an approved pharmaceutical, which shapes how studies are designed, funded, and reported.
BPC-157 is a synthetic pentadecapeptide with the sequence GEPPPGKPADDAGLV, corresponding to a partial fragment of a larger protein detected in human gastric juice. The name derives from the parent protein designation BPC, an abbreviation of body protection compound, with 157 acting as a fraction or batch identifier used by the original investigators. Its molecular weight is approximately 1419 daltons, and the chain contains no unusual residues or disulfide bridges. In the literature it is described as a short, water-soluble fragment rather than a complete natural protein.
Most published work on BPC-157 comes from animal experiments rather than controlled human trials. Rodent models have examined its effects on gastrointestinal lesions, tendon and ligament injury, and blood vessel formation. These studies are often small and originate from a limited number of research groups, which affects how broadly the findings can be generalized. No large randomized human trial has been reported in the peer-reviewed literature. Discussion of the compound therefore rests largely on preclinical data, and questions about its effects in people remain open rather than settled.
Several mechanisms have been proposed to explain the activity observed in animal models. The most frequently cited involve signaling through vascular endothelial growth factor receptor 2 and modulation of the nitric oxide system. Researchers have also described interactions with protective pathways in the gut lining. These proposed mechanisms appear in the literature as hypotheses supported by preclinical observations, not as confirmed pathways in humans. The precise way the peptide produces its reported effects, and whether those effects carry across species, remain areas of active and unresolved investigation.
BPC-157 is a synthetic peptide composed of fifteen amino acids. Its sequence corresponds to part of a protein found in human gastric juice, which is the origin of the "body protection compound" label. In laboratory work the material is treated as a defined research chemical rather than a finished product. Published research has centered on animal models, and the peptide is not an approved medicine in most countries.
The peptide was first described in the early 1990s by a group studying gastric secretions and tissue repair. Its fifteen-residue chain is usually written as GEPPPGKPADDAGLV in single-letter code. The free peptide has the formula C62H98N16O22 and a theoretical mass near 1419.5 daltons. These identifiers are established chemical facts that can be checked against standard peptide databases. There is no ambiguity about the primary structure.
== Side effects == Patients, physicians and researchers say usual, expected side effects include; temporary redness, pain and tenderness during injections and swelling and bruising at the injection sites. The more serious side effects include: immune system reactions which result in facial lumps and bumps known as granulomas, bothersome reactions which are very difficult for physicians to treat. According to Allergan, Juvéderm should not be used in patients with severe allergies, particularly those who have allergies to bacterial proteins or patients with a history of anaphylaxis, which is a potentially life-threatening hypersensitivity to some drugs and proteins.
It is believed that honokiol acts on GABAA receptors similarly to benzodiazepines and Z-drugs. However, honokiol has been shown to achieve anxiolysis with fewer motor or cognitive side effects than GABAA receptor agonists such as flurazepam and diazepam. It has been shown that honokiol likely has a higher selectivity for different GABAA receptor subtypes and both magnolol and honokiol showed higher efficacy when acting on receptors containing δ subunits. GABAA receptors control ligand-gated Cl− channels that can help increase seizure thresholds through the influx of chloride anions. Honokiol may also affect the synthesis of GABA. In a study where mice received seven daily injections of honokiol, researchers observed a mild increase in hippocampal levels of glutamate decarboxylase (GAD67) an enzyme that catalyzes the synthesis of GABA. However, the increase was within the margin of error for the method used to quantify the protein.
== Multiplayer mods == Age of Chivalry - A multiplayer modification. Players fight for either the Mason Order or Agathian Knights in a fictional medieval environment using swords, spears and many other medieval weapons. The mod was released on September 10, 2007. Age of Chivalry received Mod DB Editor's Choice for 2007. Counter-Strike: Malvinas - A multiplayer first-person shooter modification of Counter-Strike: Source, developed and distributed by Argentine web hosting company Dattatec. The game is set in Stanley, the capital of the Falkland Islands. The objective of the game is same to that of the Counter-Strike series; each round is won by either detonating a bomb or by eliminating all members of the enemy team. The mod prompted strong controversy in the United Kingdom; Dattatec's website was targeted by British hackers on March 27, 2013. Dino D-Day - The game is set in 1942 during World War II. The premise of the game is that Adolf Hitler has resurrected dinosaurs, and players can battle online choosing to serve either the Allied nations or the Nazis. Dystopia - A cyberpunk-themed total conversion, somewhat based on popular role-playing game Shadowrun, that pits Punk mercenaries against corporate security forces in both the physical world and cyberspace. Last release August 23, 2014. Dystopia received the Player's Choice Honorable Mention from Mod DB in 2006, Best Mod for Half-Life 2 during the Independent Games Festival in 2006, and received the "Mod Of The Year - 3rd place" and "Genre Award - Action" for mods of 2005 by Mod DB.
An analytical profile index is a fast identification system based on biochemical incubation tests. Usually, this test is used to quickly diagnose clinically relevant bacteria by allowing physicians to run about 20 tests at one time.
Sources: en.wikipedia.org
"Hem. Marker study, ADULTS over 16 years;Asc";Hem. Marker examination, ADULTS over 16 years, Ascites fluid;Hematology marker laboratory "Erythrocytes;Asc";"Asc-Erythrocytes; count";Clinical Biochemistry Laboratory "Erythrocytes;Asc";"Asc-Erythrocytes; numberk";, Clinical Biochemistry Laboratory "Leukocytes(mononuclear);Asc";"Asc-Leukocytes(mononuclear); count";Clinical Biochemistry Laboratory "Leukocytes(polynucleus);Asc";"Asc-Leukocytes(polynucleus); count";Clinical Biochemistry Laboratory "Nucleated cells;Asc";"Asc-Nucleated cells; count";Clinical Biochemistry Laboratory "Nucleated cells;Asc";"Asc-Nucleated cells; numberk";Clinical Biochemistry Laboratory "Carbamide;Asc";"Asc-Carbamide; substancek";Clinical Biochemistry Laboratory "Calcium;Asc";"Asc-Calcium(II); substance c.";Clinical Biochemistry Laboratory "Phosphate;Asc";"Asc-Phosphate(P; inorganic); substance";Clinical Biochemistry Laboratory "Triglyceride;Asc";"Asc-Triglyceride; substance";Clinical Biochemistry Laboratory "Bilirubins;Asc";Asc-Bilirubins, substance;Clinical Biochemistry Laboratory "Albumin;Asc";"Asc-Albumin; bulk";Clinical Biochemistry Laboratory "Protein;Asc";"Asc-Protein; mass spec.";Clinical Biochemistry Laboratory "Amylase, pancreatic type;Asc";"Asc-Amylase, pancreatic type;cat.k.";Clinical Biochemistry Laboratory "Lactate dehydro ase;Asc";"Asc-Lactate dehydro ase;.";Clinical Biochemistry Laboratory "Cholesterol;Asc";"Asc-Cholesterol+ester; substance c.";Clinical Biochemistry Laboratory "Ascites group;Asc";"A Alternative list for Ascites fluid analyses: The following analyses (Normal Order Name; Designation in the laboratory; Laboratory) can be performed on the sample material Ascites fluid.
Leslie Hicks is an American full professor of analytical chemistry at the University of North Carolina at Chapel Hill. Her work primarily focuses on the study of proteomics and protein post-translational modifications using mass spectrometry, and identifying biologically active peptides in plants.
International Package operations include delivery to more than 220 countries and territories worldwide, including shipments wholly outside the United States, as well as shipments with either origin or distribution outside the United States. UPS splits its international shipping into a few services:
Presence of a pseudogap phase up to at least optimal doping. Different trends in the Uemura plot relating transition temperature to superfluid density. The inverse square of the London penetration depth appears to be proportional to the critical temperature for a large number of underdoped cuprate superconductors, but the constant of proportionality is different for hole- and electron-doped cuprates. The linear trend implies that the physics of these materials is strongly two-dimensional. Universal hourglass-shaped feature in the spin excitations of cuprates measured using inelastic neutron diffraction. Nernst effect evident in both the superconducting and pseudogap phases.
== Terminology == Antigens can be proteins, polysaccharides, lipids, nucleic acids or other biomolecules. This includes parts (coats, capsules, cell walls, flagella, fimbriae, and toxins) of bacteria, viruses, and other microorganisms. Non-microbial non-self antigens can include pollen, egg white, and proteins from transplanted tissues and organs or on the surface of transfused blood cells.
Sources: en.wikipedia.org
Animal experiments form the bulk of the published record. Rodent models of tendon, ligament, bone, and gut injury are the most common designs. Controlled human trials are rare, which limits confidence in any clinical claim.
They are best described as working hypotheses. Supporting data come mainly from cell cultures and animal tissue, using markers such as growth factors and inflammatory signals. Confirmatory human studies have not been reported.
Status depends on the country. In some places it is treated as a research chemical available without a prescription, while elsewhere it falls under prescription or controlled rules. It holds no general marketing approval as a therapeutic product.
Lyophilised peptide powders are generally kept frozen or refrigerated, dry, and protected from light. Sealed vials limit moisture uptake and slow hydrolysis. Such guidance comes from general peptide chemistry rather than from stability studies specific to every product.